US Patent 11279688 Inhibitors of RET
Patent 11279688 was granted and assigned to Blueprint Medicines on March, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 29, 2020
Date of Patent
March 22, 2022
Patent Applicant
Patent Application Number
16775646
Patent Citations
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11279688 Inhibitors of RET
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
